| 1 | 0.9% sodium chloride | Chloride ion | 1件: D02056D02056 💬 | - | - | 0064件:  6 , 14, 51, 53 💬 | 
| 2 | 0.9% sodium chloride (normal saline) | Chloride ion | 1件: D02056D02056 💬 | - | - | 0061件:  6  💬 | 
| 3 | 0.9% sodium chloride injection | Chloride ion | 1件: D02056D02056 💬 | - | - | 1681件: 168 💬 | 
| 4 | 0.9% w/v isotonic sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 0501件: 50 💬 | 
| 5 | 0.9% w/v sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 6 | Continuous infusion meropenem | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 7 | Dexmedetomidine | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 00212件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 | 
| 8 | Dexmedetomidine 1 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 9 | Dexmedetomidine 2 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 10 | Dexmedetomidine 3 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 11 | Dexmedetomidine group | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 12 | Dexmedetomidine hydrochloride | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 13 | Dexmedetomidine hydrochloride infusion | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 14 | Dexmedetomidine with ropivacaine | Dexmedetomidine | 4件: D00514D00514, D01205D01205, D04048D04048, D08490D08490 💬 | ADRA2A8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | Adrenergic signaling in cardiomyocytes5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 15 | Fentanyl (low dose) + dexmedetomidine | Dexmedetomidine | 4件: D00320D00320, D00514D00514, D01205D01205, D01399D01399 💬 | ADRA2A4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | Estrogen signaling pathway4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2151件: 215 💬 | 
| 16 | Fluconazole | Fluconazole | 2件: D00322D00322, D01429D01429 💬 | - | - | 0962件: 96, 225 💬 | 
| 17 | Intermittent, short infusion meropenem | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 18 | Isotonic sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 0341件: 34 💬 | 
| 19 | Iv meropenem | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 20 | Levetiracetam | Levetiracetam | 1件: D00709D00709 💬 | SV2A1件: SV2A 💬 | ECM-receptor interaction1件: ECM-receptor interaction | 0024件:  2 ,  4 ,  6 , 13 💬 | 
| 21 | Meropenem | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 0602件: 60, 299 💬 | 
| 22 | Meropenem fresenius kabi | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 23 | Meropenem fresenius kabi 1 g poeder voor oplossing voor injectie of infusie | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 24 | Meropenem infusion | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 25 | Meropenem trihydrate | Meropenem | 2件: D02222D02222, D08185D08185 💬 | - | - | 2991件: 299 💬 | 
| 26 | Other: 0.9% sodium chloride | Chloride ion | 1件: D02056D02056 💬 | - | - | 0651件: 65 💬 | 
| 27 | Other: 0.9ml sodium chloride | Chloride ion | 1件: D02056D02056 💬 | - | - | 2711件: 271 💬 | 
| 28 | Other: sodium chloride | Chloride ion | 1件: D02056D02056 💬 | - | - | 0511件: 51 💬 | 
| 29 | Physiological serum (sodium chloride) | Chloride ion | 1件: D02056D02056 💬 | - | - | 1931件: 193 💬 | 
| 30 | Procedure: 9% sodium chloride (nacl) iv | Chloride ion | 1件: D02056D02056 💬 | - | - | 0781件: 78 💬 | 
| 31 | Scopolamine, atropine, edaravone and dexmedetomidine | Atropine | 9件: D00113D00113, D00138D00138, D00514D00514, D01077D01077, D01205D01205, D01552D01552, D02069D02069, D03011D03011, D03814D03814 💬 | ADRA2A8件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | Alzheimer disease14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0021件:  2  💬 | 
| 32 | Sodium chloride | Chloride ion | 1件: D02056D02056 💬 | - | - | 00620件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 | 
| 33 | Sodium chloride (7%) | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 34 | Sodium chloride 0,9% | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 35 | Sodium chloride 0.9% | Chloride ion | 1件: D02056D02056 💬 | - | - | 0141件: 14 💬 | 
| 36 | Sodium chloride 6% | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 37 | Sodium chloride 7% | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 38 | Sodium chloride ph. eur. | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 39 | Sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 0113件: 11, 13, 228 💬 | 
| 40 | Sodium chloride solution 0.9% | Chloride ion | 1件: D02056D02056 💬 | - | - | 0603件: 60, 288, 299 💬 | 
| 41 | Sodium chloride solvent | Chloride ion | 1件: D02056D02056 💬 | - | - | 2281件: 228 💬 | 
| 42 | Sodium pyruvate in 0.9% sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 2991件: 299 💬 | 
| 43 | Solucion de cloruro de sodio sodium chloride solution | Chloride ion | 1件: D02056D02056 💬 | - | - | 2281件: 228 💬 | 
| 44 | Solvente cloruro de sodio sodium chloride solvent | Chloride ion | 1件: D02056D02056 💬 | - | - | 2281件: 228 💬 | 
| 45 | Tranexamic acid | Tranexamic acid | 1件: D01136D01136 💬 | PLG1件: PLG 💬 | Complement and coagulation cascades4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection | 0465件: 46, 70, 215, 227, 288 💬 | 
| 46 | Tranexamic acid 100 mg/ml | Tranexamic acid | 1件: D01136D01136 💬 | PLG1件: PLG 💬 | Complement and coagulation cascades4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection | 0701件: 70 💬 | 
| 47 | Tranexamic acid injection [cyklokapron] | Tranexamic acid | 1件: D01136D01136 💬 | PLG1件: PLG 💬 | Complement and coagulation cascades4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection | 2881件: 288 💬 |